Wells Fargo
HCAT icon

Wells Fargo’s Health Catalyst HCAT Stock Holding History

Wells Fargo’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.8K Sell
26,627
-53,705
-67% -$101K ﹤0.01% 5581
2025
Q4 		$192K Sell
80,332
-6,951
-8% -$19K ﹤0.01% 5090
2025
Q3 		$249K Buy
87,283
+37,883
+77% +$130K ﹤0.01% 4808
2025
Q2 		$186K Buy
49,400
+9,105
+23% +$35.8K ﹤0.01% 4814
2025
Q1 		$183K Buy
40,295
+940
+2% +$4.97K ﹤0.01% 4773
2024
Q4 		$278K Buy
39,355
+8,451
+27% +$67.3K ﹤0.01% 4584
2024
Q3 		$252K Buy
30,904
+4,686
+18% +$33.9K ﹤0.01% 4420
2024
Q2 		$168K Buy
26,218
+1,665
+7% +$10.7K ﹤0.01% 4629
2024
Q1 		$185K Buy
24,553
+2,559
+12% +$23.4K ﹤0.01% 4518
2023
Q4 		$204K Buy
21,994
+6,487
+42% +$53K ﹤0.01% 4453
2023
Q3 		$157K Sell
15,507
-7,542
-33% -$90K ﹤0.01% 4506
2023
Q2 		$288K Buy
23,049
+12,619
+121% +$150K ﹤0.01% 4351
2023
Q1 		$122K Buy
10,430
+10,094
+3,004% +$129K ﹤0.01% 4711
2022
Q4 		$3.57K Sell
336
-214
-39% -$2.07K ﹤0.01% 5864
2022
Q3 		$5K Sell
550
-1,664
-75% -$22K ﹤0.01% 5903
2022
Q2 		$31K Sell
2,214
-20,081
-90% -$342K ﹤0.01% 5251
2022
Q1 		$582K Sell
22,295
-16,881
-43% -$479K ﹤0.01% 4307
2021
Q4 		$1.55M Buy
39,176
+22,381
+133% +$1.02M ﹤0.01% 3741
2021
Q3 		$840K Buy
16,795
+13,876
+475% +$757K ﹤0.01% 4355
2021
Q2 		$162K Sell
2,919
-29,341
-91% -$1.56M ﹤0.01% 5119
2021
Q1 		$1.51M Sell
32,260
-56,825
-64% -$2.75M ﹤0.01% 3938
2020
Q4 		$3.88M Sell
89,085
-2,336,749
-96% -$86.2M ﹤0.01% 2974
2020
Q3 		$88.8M Buy
2,425,834
+1,927,190
+386% +$65.4M 0.02% 614
2020
Q2 		$14.5M Sell
498,644
-612,811
-55% -$16.9M ﹤0.01% 1577
2020
Q1 		$29.1M Buy
1,111,455
+927,194
+503% +$28.3M 0.01% 1043
2019
Q4 		$6.39M Sell
184,261
-424,926
-70% -$14.1M ﹤0.01% 2345
2019
Q3 		$19.3M Buy
+609,187
New +$24M 0.01% 1461

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo's HCAT Position: Q1 2026 in Review

Wells Fargo reduced its Health Catalyst (HCAT) stake by 67% in Q1 2026, selling an estimated $101K and leaving 26,627 shares worth $33.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5581.

Wells Fargo first reported a position in HCAT in Q3 2019 and has held it in 27 quarters since. The position peaked at $88.8M in Q3 2020. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Wells Fargo held 26,627 shares of Health Catalyst worth $33.8K as of Q1 2026.
  • Wells Fargo sold 53,705 Health Catalyst shares in Q1 2026, an estimated $101K.
  • Health Catalyst made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5581 holding.
  • Wells Fargo first reported a position in Health Catalyst in Q3 2019 and has held it in 27 quarters since.
  • Wells Fargo's Health Catalyst position peaked at $88.8M in Q3 2020.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.